📊 FTII Key Takeaways
Is FTII a Good Investment? Thesis Analysis
FutureTech II is a financially distressed acquisition company with negative stockholders' equity of -9.6M, indicating the company is technically insolvent. Severe liquidity constraints (current ratio of 0.21x) combined with negative operating cash flow of -1.2M and a cash position of only 160.7K creates an existential crisis. The company is burning cash rapidly with no revenue generation and mounting losses, making it unsuitable for equity investment.
Why Buy FTII? Key Strengths
- Company has not yet filed for bankruptcy or ceased operations
- Minimal insider selling pressure in last 90 days suggests no forced liquidations
- May have acquisition or reverse merger potential as a shell entity
FTII Investment Risks to Consider
- Negative stockholders' equity of -9.6M indicates technical insolvency and shareholder claims are fully subordinated to creditors
- Critical liquidity crisis: current ratio of 0.21x with only 160.7K cash against 10.4M liabilities threatens immediate solvency
- Severe cash burn: negative operating cash flow of -1.2M annually with no revenue means remaining cash runway is less than 2 months
- No revenue generation capability documented; operating losses of -320.3K indicate ongoing operations without income
- Interest coverage ratio of -3.2x shows inability to service debt obligations
- ROA of -3.5% confirms systematic destruction of asset value
Key Metrics to Watch
- Stockholders' equity trend - any further deterioration below -9.6M signals complete loss of equity cushion
- Cash balance - depletion below 100K would indicate imminent insolvency crisis
- Operating cash flow - must return to positive to assess viability; current -1.2M trajectory unsustainable
- Acquisition or merger announcement - structural solution required for survival
- Debt covenant compliance status and default risk timeline
FTII Financial Metrics
💡 AI Analyst Insight
The current ratio below 1.0x warrants monitoring of short-term liquidity.
FTII Profitability Ratios
FTII vs Healthcare Sector
How FutureTech II Acquisition Corp. compares to Healthcare sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is FTII Overvalued or Undervalued?
Based on fundamental analysis, FutureTech II Acquisition Corp. has mixed fundamental signals relative to the Healthcare sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
FTII Balance Sheet & Liquidity
FTII 5-Year Financial Trend & Growth Analysis
5-Year Trend Summary: FutureTech II Acquisition Corp.'s revenue has remained relatively flat over the 5-year period, with a 0% decline.
FTII Growth Metrics (YoY)
FTII Capital Allocation
FTII SEC 10-K & 10-Q Filing Analysis
Access official SEC EDGAR filings for FutureTech II Acquisition Corp. (CIK: 0001889450)
📋 Recent SEC Filings
❓ Frequently Asked Questions about FTII
What is the AI rating for FTII?
FutureTech II Acquisition Corp. (FTII) has an AI rating of STRONG SELL with 95% confidence, based on fundamental analysis of SEC EDGAR filings.
What are FTII's key strengths?
Claude: Company has not yet filed for bankruptcy or ceased operations. Minimal insider selling pressure in last 90 days suggests no forced liquidations.
What are the risks of investing in FTII?
Claude: Negative stockholders' equity of -9.6M indicates technical insolvency and shareholder claims are fully subordinated to creditors. Critical liquidity crisis: current ratio of 0.21x with only 160.7K cash against 10.4M liabilities threatens immediate solvency.
What is FTII's revenue and growth?
FutureTech II Acquisition Corp. reported revenue of N/A.
Does FTII pay dividends?
FutureTech II Acquisition Corp. does not currently pay dividends.
Where can I find FTII SEC filings?
Official SEC filings for FutureTech II Acquisition Corp. (CIK: 0001889450) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is FTII's EPS?
FutureTech II Acquisition Corp. has a diluted EPS of $0.00.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.
Is FTII a good stock to buy right now?
Based on our AI fundamental analysis in March 2026, FutureTech II Acquisition Corp. has a STRONG SELL rating with 95% confidence. Review the strengths and risks sections above before making a decision. This is not investment advice.
Is FTII stock overvalued or undervalued?
Valuation metrics for FTII: ROE of N/A (sector avg: 15%), net margin of N/A (sector avg: 12%). Compare these metrics with sector averages to assess valuation.
Should I buy FTII stock in 2026?
Our dual AI analysis gives FutureTech II Acquisition Corp. a combined STRONG SELL rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is FTII's free cash flow?
FutureTech II Acquisition Corp.'s operating cash flow is $-1.2M, with capital expenditures of N/A.
How does FTII compare to other Healthcare stocks?
Vs Healthcare sector averages: Net margin N/A (avg: 12%), ROE N/A (avg: 15%), current ratio 0.21 (avg: 2).